Nifty
Sensex
:
:
16352.45
54884.66
182.30 (1.13%)
632.13 (1.17%)

Pharmaceuticals & Drugs

Rating :
42/99

BSE: 500009 | NSE: AMBASARABH

30.75
26-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  30.00
  •  31.20
  •  29.35
  •  29.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  266
  •  14.73
  •  65.00
  •  27.40

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 235.65
  • 4.29
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 233.00
  • N/A
  • 2.09

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 30.76%
  • 2.45%
  • 62.41%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 4.38%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.28
  • 4.10
  • 2.52

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -18.79
  • -32.60
  • 33.88

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.51
  • -14.52
  • 116.30

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.46
  • 6.26
  • 9.85

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.32
  • 3.48
  • 3.46

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.44
  • 1.76
  • 8.66

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Net Sales
43.10
46.05
-6.41%
56.49
42.42
33.17%
42.73
26.72
59.92%
48.46
38.56
25.67%
Expenses
36.75
45.41
-19.07%
46.61
39.07
19.30%
35.45
26.62
33.17%
54.33
37.19
46.09%
EBITDA
6.34
0.63
906.35%
9.88
3.35
194.93%
7.28
0.10
7,180.00%
-5.87
1.37
-
EBIDTM
14.72%
1.38%
17.50%
7.89%
17.04%
0.38%
-12.12%
3.55%
Other Income
0.65
1.58
-58.86%
2.10
2.14
-1.87%
30.73
1.55
1,882.58%
25.31
15.93
58.88%
Interest
0.33
0.81
-59.26%
0.34
0.78
-56.41%
0.59
0.82
-28.05%
0.54
0.85
-36.47%
Depreciation
0.58
0.67
-13.43%
0.56
0.59
-5.08%
0.56
0.65
-13.85%
0.50
1.03
-51.46%
PBT
6.09
0.73
734.25%
10.97
4.12
166.26%
21.86
0.19
11,405.26%
18.39
15.41
19.34%
Tax
2.19
1.24
76.61%
1.42
0.97
46.39%
2.14
0.40
435.00%
0.58
1.10
-47.27%
PAT
3.89
-0.50
-
9.56
3.15
203.49%
19.72
-0.22
-
17.82
14.31
24.53%
PATM
9.03%
-1.09%
16.92%
7.42%
46.16%
-0.81%
36.77%
37.11%
EPS
0.46
0.26
76.92%
1.24
1.41
-12.06%
3.47
0.12
2,791.67%
2.04
1.69
20.71%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
190.78
163.64
133.50
151.88
125.00
133.88
131.98
124.50
104.65
100.24
88.98
Net Sales Growth
24.08%
22.58%
-12.10%
21.50%
-6.63%
1.44%
6.01%
18.97%
4.40%
12.65%
 
Cost Of Goods Sold
107.50
99.97
79.34
89.52
70.20
76.92
72.88
72.73
58.10
54.18
51.56
Gross Profit
83.28
63.68
54.16
62.36
54.81
56.95
59.11
51.76
46.55
46.07
37.42
GP Margin
43.65%
38.91%
40.57%
41.06%
43.85%
42.54%
44.79%
41.57%
44.48%
45.96%
42.05%
Total Expenditure
173.14
165.18
135.40
145.99
136.74
144.95
144.67
128.83
113.27
110.61
101.33
Power & Fuel Cost
-
2.86
2.71
3.22
2.84
2.68
3.67
2.80
2.36
2.97
2.11
% Of Sales
-
1.75%
2.03%
2.12%
2.27%
2.00%
2.78%
2.25%
2.26%
2.96%
2.37%
Employee Cost
-
28.17
27.06
26.02
26.67
28.71
31.29
28.47
27.39
30.28
26.86
% Of Sales
-
17.21%
20.27%
17.13%
21.34%
21.44%
23.71%
22.87%
26.17%
30.21%
30.19%
Manufacturing Exp.
-
5.74
4.07
5.09
5.18
5.43
7.13
5.53
6.00
5.12
4.53
% Of Sales
-
3.51%
3.05%
3.35%
4.14%
4.06%
5.40%
4.44%
5.73%
5.11%
5.09%
General & Admin Exp.
-
10.40
11.94
10.92
24.21
12.52
13.39
10.03
9.56
8.93
7.09
% Of Sales
-
6.36%
8.94%
7.19%
19.37%
9.35%
10.15%
8.06%
9.14%
8.91%
7.97%
Selling & Distn. Exp.
-
10.51
7.03
7.92
4.86
6.53
6.42
6.08
4.66
4.11
4.12
% Of Sales
-
6.42%
5.27%
5.21%
3.89%
4.88%
4.86%
4.88%
4.45%
4.10%
4.63%
Miscellaneous Exp.
-
7.53
3.26
3.30
2.79
12.16
9.90
3.19
5.18
5.02
4.12
% Of Sales
-
4.60%
2.44%
2.17%
2.23%
9.08%
7.50%
2.56%
4.95%
5.01%
5.68%
EBITDA
17.63
-1.54
-1.90
5.89
-11.74
-11.07
-12.69
-4.33
-8.62
-10.37
-12.35
EBITDA Margin
9.24%
-0.94%
-1.42%
3.88%
-9.39%
-8.27%
-9.62%
-3.48%
-8.24%
-10.35%
-13.88%
Other Income
58.79
30.58
24.39
5.47
25.04
6.22
95.08
12.99
3.01
16.41
4.08
Interest
1.80
3.20
3.61
3.29
3.41
4.77
4.10
9.83
10.93
8.52
9.69
Depreciation
2.20
2.41
2.57
2.10
2.12
4.27
16.54
4.81
3.01
14.02
2.90
PBT
57.31
23.43
16.31
5.97
7.77
-13.90
61.74
-5.98
-19.55
-16.50
-20.86
Tax
6.33
3.19
0.88
3.97
6.69
4.61
13.61
0.69
0.66
1.48
1.04
Tax Rate
11.05%
13.62%
5.40%
66.50%
86.10%
-33.17%
22.04%
-11.54%
-3.38%
-8.97%
-10.75%
PAT
50.99
20.24
15.44
2.00
1.08
-18.51
48.14
-6.67
-20.21
-17.97
-10.71
PAT before Minority Interest
50.99
20.24
15.44
2.00
1.08
-18.51
48.14
-6.67
-20.21
-17.97
-10.71
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
26.73%
12.37%
11.57%
1.32%
0.86%
-13.83%
36.48%
-5.36%
-19.31%
-17.93%
-12.04%
PAT Growth
204.60%
31.09%
672.00%
85.19%
-
-
-
-
-
-
 
EPS
6.66
2.64
2.02
0.26
0.14
-2.42
6.28
-0.87
-2.64
-2.35
-1.40

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
73.90
44.77
30.62
26.52
25.17
38.73
-9.40
-2.16
17.94
36.46
Share Capital
76.63
76.63
76.63
76.63
76.63
76.63
76.63
76.63
76.63
76.63
Total Reserves
-2.74
-31.87
-46.01
-50.12
-51.46
-37.90
-86.04
-78.79
-58.69
-40.18
Non-Current Liabilities
5.35
4.81
8.90
11.39
5.83
12.70
15.43
59.01
17.14
15.99
Secured Loans
5.17
4.54
8.76
11.12
5.11
5.72
5.76
3.20
4.09
3.25
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.02
0.00
0.00
0.00
0.00
Long Term Provisions
2.25
3.37
3.80
4.38
5.53
6.75
9.85
55.84
12.33
12.30
Current Liabilities
128.54
133.47
171.32
155.44
124.43
152.51
162.77
154.55
175.34
170.71
Trade Payables
50.40
40.02
46.83
39.76
29.14
26.93
27.54
28.33
21.13
33.31
Other Current Liabilities
52.43
64.73
91.29
80.43
50.08
56.70
91.85
86.32
73.61
65.73
Short Term Borrowings
21.85
24.80
28.76
30.34
35.33
39.50
38.92
36.67
33.45
24.55
Short Term Provisions
3.86
3.92
4.44
4.91
9.88
29.38
4.46
3.22
47.15
47.12
Total Liabilities
207.78
183.04
210.83
193.35
155.43
203.94
168.80
211.40
210.42
223.16
Net Block
56.86
57.46
57.65
59.16
72.25
71.76
90.78
94.32
98.39
111.21
Gross Block
69.77
68.24
65.91
65.36
76.34
138.02
153.64
152.39
154.51
155.91
Accumulated Depreciation
12.91
10.78
8.26
6.20
4.09
66.26
62.86
58.07
56.11
44.69
Non Current Assets
87.19
79.06
94.58
79.79
82.18
91.54
100.43
143.97
105.56
122.72
Capital Work in Progress
0.77
0.41
24.06
13.69
3.44
8.97
0.83
0.21
0.10
0.12
Non Current Investment
27.30
18.14
9.36
5.37
4.83
8.10
0.62
0.78
1.30
2.29
Long Term Loans & Adv.
1.48
2.11
1.98
1.48
1.50
1.95
7.73
48.44
2.79
2.61
Other Non Current Assets
0.78
0.94
1.53
0.10
0.17
0.77
0.48
0.22
2.98
6.48
Current Assets
120.59
103.98
116.26
113.55
73.25
112.40
68.37
67.43
104.85
100.43
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.27
0.15
0.00
0.00
Inventories
15.97
16.45
14.98
14.39
13.81
14.41
17.10
15.13
13.72
12.19
Sundry Debtors
38.81
28.80
34.69
34.13
28.95
30.11
25.29
27.18
27.84
21.91
Cash & Bank
31.38
21.53
23.26
22.07
16.71
16.41
13.85
12.28
7.16
9.46
Other Current Assets
34.42
11.25
15.94
25.29
13.77
51.47
11.86
12.68
56.14
56.87
Short Term Loans & Adv.
22.65
25.95
27.39
17.66
11.38
37.98
11.41
11.18
54.83
55.48
Net Current Assets
-7.95
-29.49
-55.06
-41.89
-51.18
-40.11
-94.40
-87.12
-70.48
-70.28
Total Assets
207.78
183.04
210.84
193.34
155.43
203.94
168.80
211.40
210.41
223.15

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
-2.30
-6.88
18.80
-7.39
5.40
-74.99
-8.32
11.02
-3.26
-12.80
PBT
32.54
14.94
8.21
7.96
-13.62
61.74
-5.98
-19.55
-16.50
-9.67
Adjustment
-24.92
-13.26
1.79
-11.90
17.83
-67.13
2.50
14.47
6.76
-1.90
Changes in Working Capital
-7.96
-6.07
16.64
16.46
2.77
-64.49
-0.39
17.76
8.26
8.98
Cash after chg. in Working capital
-0.34
-4.40
26.65
12.53
6.98
-69.88
-3.88
12.67
-1.48
-2.60
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.96
-2.48
-7.84
-19.93
-1.58
-5.12
-4.44
-1.66
-1.78
-10.21
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
10.09
16.89
-9.25
17.58
-3.31
80.06
9.80
-0.89
-0.28
10.79
Net Fixed Assets
0.13
-0.23
-0.06
1.03
56.92
20.63
0.40
0.84
2.06
0.91
Net Investments
29.85
2.59
-0.09
8.92
6.72
-26.62
-0.13
1.83
0.50
-1.55
Others
-19.89
14.53
-9.10
7.63
-66.95
86.05
9.53
-3.56
-2.84
11.43
Cash from Financing Activity
-5.84
-14.22
-6.07
-2.09
-6.26
-3.44
-0.61
-8.39
2.75
0.65
Net Cash Inflow / Outflow
1.95
-4.21
3.49
8.10
-4.17
1.62
0.87
1.74
-0.79
-1.36
Opening Cash & Equivalents
12.79
17.00
13.51
5.41
9.58
8.40
7.53
5.79
6.58
7.93
Closing Cash & Equivalent
14.74
12.79
17.00
13.51
5.41
10.03
8.40
7.53
5.79
6.58

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
9.64
5.84
4.00
3.46
3.28
5.05
-1.23
-0.28
2.34
4.76
ROA
10.36%
7.84%
0.99%
0.62%
-10.30%
25.83%
-3.51%
-9.58%
-8.29%
-4.62%
ROE
34.12%
40.95%
7.01%
4.20%
-57.92%
328.25%
0.00%
-256.13%
-66.09%
-25.55%
ROCE
29.83%
27.14%
13.17%
16.34%
-11.94%
107.14%
10.08%
-17.91%
-12.98%
0.02%
Fixed Asset Turnover
2.42
2.06
2.34
1.77
1.27
0.93
0.83
0.70
0.66
0.59
Receivable days
73.84
83.82
81.74
91.65
79.06
74.77
75.18
93.62
88.35
106.91
Inventory Days
35.41
41.50
34.90
40.98
37.78
42.53
46.19
49.09
46.00
44.61
Payable days
165.09
199.78
117.80
109.36
81.80
71.83
85.02
86.62
87.50
128.12
Cash Conversion Cycle
-55.84
-74.47
-1.16
23.27
35.04
45.47
36.35
56.09
46.86
23.40
Total Debt/Equity
0.39
0.70
1.31
1.63
1.67
1.22
-4.94
-19.21
2.17
0.81
Interest Cover
8.33
5.52
2.81
3.28
-1.91
16.06
0.39
-0.79
-0.94
0.00

News Update:


  • Ambalal Sarabhai’s arm’s JV gets nod to manufacture, sell SARAQ HCV viral load kit
    21st Apr 2022, 12:15 PM

    This HCV Viral Load kit test adds to expanding menu of valuable diagnostic tools available to company’s growing distributor and laboratory customer base

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.